Immunoglobulin as an eosinophil degranulation factor: Change in immunoglobulin level in nasal lavage fluid after antigen challenge

Acta Oto-Laryngologica

Volumn 116, Issue 6, 1996, Pages 863-867

  Terada, Nobuhisa ^a   Terada, Yoshie ^a   Shirotori, Kohji ^b   Ishikawa, Kazuo ^b   Togawa, Kiyoshi ^b   Konno, Akiyoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b AKITA UNIVERSITY   (Japan)

Author keywords

Eosinophil; Eosinophil cationic protein; IgA; Late phase response; Nasal allergy; Nasal lavage; Secretory IgA

Indexed keywords

IMMUNOGLOBULIN A; SECRETORY IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; EOSINOPHIL; HUMAN; POLLEN ALLERGY; PRIORITY JOURNAL;

EID: 0029856081     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016489609137942     Document Type: Article

References (18)

1. Kurono Y, Fujiyoshi T, Mogi G. Secretory IgA and bacterial adherence to nasal mucosal cells. Ann Otol Rhino Laryngol 1989; 98: 273-7.
2. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989; 142: 2393-400.
3. Fujisawa T, Abu-Gazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990; 144: 642-6.
4. Venge P, Roxin LE, Olsson I. Radioimmunoassay of human eosinophil cationic protein. Br J Haematol 1977; 37: 331-5.
5. Fujita S. Determination of serum immunoglobulins and α-fetoprotein by latex agglutination photometric immunoassay. Jpn J Clin Lab Auto 1983; 8: 57-61.
6. Takahashi T. A study on measurement of the IgA, the secretion-type, in human saliva, using the enzyme immunoassay (EIA) method. Nihon Univ Dent J 1984; 58: 627-35 (in Japanese).
7. Terada N, Konno A, Tada H, Shirotori K, Ishikawa K, Togawa K. The effect of recombinant interleukin-5 on eosinophil accumulation and degranuration in human nasal mucosa. J Allergy Clin Immunol 1992; 90: 160-8.
8. Terada N, Konno A, Togawa K. Biochemical properties of eosinophils and mechanism of their preferential accumulation in nasal allergy. J Allergy Clin Immunol 1994; 94: 629-42.
9. Dahl R, Fredens K, Marcussen C, Venge P. Eosinophils and bronchial injury. Annual Meeting of European Academy of Allergology and Clinical Immunology 1985; (Abstr): 63976.
10. Frigas R, Loegering DA, Gleich GJ. Cytotoxic effects of the guinea pig eosinophil major basic protein in tracheal epithelium. Lab Invest 1990; 42: 35-43.
11. Konno A, Terada N, Ito E, Okamoto Y, Togawa K. The reaction of the nasal mucosa to platelet activating factor and leukotriens in nasal allergy. ORL Tokyo 1988; 31 (Suppl 7): 241-2.
12. Terada N, Konno A, Fukuda S, et al. Interleukin-5 gene expression in nasal mucosa and changes in amount of interleukin-5 in nasal lavage after antigen challenge. Acta Otolaryngol (Stockh) 1994; 114: 203-8.
13. Sanderson C, Warren D, Strath M. Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to IL3, and functional properties of eosinophil differentiation in cultures. J Exp Med 1985; 162: 60-6.
14. Clutterbuck EJ, Hurst EMA, Sanderson CJ. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GMCSF. Blood 1989; 73: 1504-12.
15. Harriman GR, Kunimoto DY, Elliott JF, Paetkau V, Strober W. The role of IL-5 in IgA B cell differentiation. J Immunol 1988; 140: 3033-9.
16. Beagley KW, Eldridge JH, Kiyono H, Everson P, Koopman WJ. Recombinant IL-5 induced high rate synthesis in cycling IgA-positive Payer's patch B cells. J Immunol 1989; 141: 2035-42.
17. Lopez AF, Sanderson CJ, Gamble JR, Campbell HD, Young IG, Vadas MA. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med 1988; 167: 219-24.
18. Rothenberg ME, Peterson J, Stevens RL, et al. IL-5 dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability: accelerated hypodensity and sustained antibody-dependent cytotoxicity. J Immunol 1989; 143: 2311-6.